CD-Chex CD34 is a ready-to-use, positive procedural control for enumerating CD34 positive cells by flow cytometry. Designed to mimic a patient sample, CD-Chex CD34 contains human leukocytes and erythrocytes in a preservative medium with CD34 positive cells having characteristics similar to human hematopoietic progenitor cells. The whole blood control does not need to be diluted and offers 30-day open-vial stability, eliminating the need to track thermal openings. Its long shelf life reduces the number of shipments, associated costs and time spent performing lot-to-lot correlation.
Streck斯特里克在70年代早期开发了细胞稳定的核心技术,当时血细胞仍在用显微镜进行人工计数。通过分离和稳定血小板,我们的科学家能够促进自动计数,并开发出校准血小板计数设备的精确系统。
如今,Streck拥有20多种产品的40多项专利,并为一些行业领先的仪器制造商(如雅培、西门子和Sysmex等)制造测试和试剂材料。
Streck位于美国的中心地带,位于内布拉斯加州拉维斯塔市,占地20万平方英尺。在这里,我们的产品被制造并交付给世界65个国家的13000多个实验室。